O17 Eliminate Hepatitis C Partnership: clinical site scoping

by E. Wong, A. Pedrana, B.L. Draper, J. Gold, J. Richmond, M. Stoove, J.S. Doyle, A.J. Thompson, M.E. Hellard
Published 2017-08-01

O20 Opportunities and challenges experienced when treating HCV in people who inject drugs (PWID) through a nurse-led outreach model

by K. Allardice, S. Von Bibra, J.S. Doyle, P.M. Dietze, P. Desmond, M. Stoove, E. McBryde, P. Higgs, A.J. Thompson, M.E. Hellard
Published 2017-08-01

Predicting outcome in clinically isolated syndrome using machine learning

by V. Wottschel, D.C. Alexander, P.P. Kwok, D.T. Chard, M.L. Stromillo, N. De Stefano, A.J. Thompson, D.H. Miller, O. Ciccarelli
Published 2015-01-01

Structural cortical network reorganization associated with early conversion to multiple sclerosis

by C. Tur, A. Eshaghi, D. R. Altmann, T. M. Jenkins, F. Prados, F. Grussu, T. Charalambous, A. Schmidt, S. Ourselin, J. D. Clayden, C. A. M. G. Wheeler-Kingshott, A. J. Thompson, O. Ciccarelli, A. T. Toosy
Published 2018-07-01

Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial

by A. J. Wade, J. S. Doyle, E. Gane, C. Stedman, B. Draper, D. Iser, S. K. Roberts, W. Kemp, D. Petrie, N. Scott, P. Higgs, P. A. Agius, J. Roney, L. Stothers, A. J. Thompson, M. E. Hellard
Published 2018-07-01